|
Endpoint
|
Hs-troponin positive (n = 12)
|
P*
|
Hs-troponin negative (n = 48)
|
P*
|
P¶
|
Pƪ
|
|---|
|
Baseline
|
After 30 days
|
Baseline
|
After 30 days
|
|---|
|
LVEF (%)
|
43.1 ± 15.4
|
43.7 ± 21.6
|
0.878
|
55
|
55.3 ± 1.2
|
0.083
|
< 0.001
|
< 0.001
|
|
Diastolic dysfunction (%)
|
3 (25)
|
2 (17)
|
0.317
|
4 (8)
|
4 (8)
|
0.346
|
0.108
|
0.389
|
|
Regional wall motion abnormalities (%)
|
5 (42)
|
3 (25)
|
0.483
|
0 (0)
|
2 (4)
|
0.511
|
< 0.001
|
0.020
|
|
LV size dilation (%)
|
5 (42)
|
2 (17)
|
0.375
|
0
|
0
|
1.00
|
< 0.001
|
0.004
|
|
Mitral regurgitation (%)
|
6 (50)
|
5 (42)
|
0.157
|
10 (63)
|
10 (21)
|
0.125
|
0.041
|
0.136
|
|
Tricuspid regurgitation (%)
|
6 (50)
|
4 (33)
|
0.572
|
7 (15)
|
7 (15)
|
0.553
|
0.008
|
0.133
|
|
Pulmonary arterial pressure (mmHg)
|
33.3 ± 9.3
|
32.9 ± 8.9
|
0.586
|
26.9 ± 5.02
|
28.9 ± 5.9
|
0.014
|
0.002
|
0.051
|
- Hs-Troponin high sensitive troponin, LVEF left ventricular ejection fraction, LV left ventricle
- * P value between baseline and after 30 days
- ¶ P value between hs-troponin positive and negative group at baseline
- ƪ P value between hs-troponin positive and negative group after 30 days
